Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
157 studies found for:    HEPATITIS B VACCINE, RESPONSE TO
Show Display Options
Rank Status Study
1 Active, not recruiting A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study
Condition: Innate Immune Response
Interventions: Drug: BCG Vaccine;   Drug: Hepatitis B Vaccine
2 Completed Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Condition: Hepatitis B
Intervention: Biological: Resiquimod gel
3 Completed
Has Results
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
4 Completed A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines
Condition: Hepatitis B
Interventions: Biological: Engerix B IM injection - 20ug;   Biological: Fendrix IM injection - 20ug
5 Completed
Has Results
Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children
Condition: Hepatitis B
Intervention: Biological: Engerix-B™ Kinder
6 Completed Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
Conditions: Hepatitis B;   Immune Response;   Seroprevalence
Intervention: Biological: HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium)
7 Completed The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
Condition: Hepatitis B
Interventions: Drug: Alendronate;   Drug: Hepatitis B Vaccine;   Drug: Placebo
8 Completed
Has Results
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
9 Unknown  Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Conditions: Chronic Hepatitis B;   Inadequate Response;   Nucleos(t)Ide Analogues Treatment
Intervention: Drug: Entecavir, Adefovir
10 Completed Dose of Hepatitis B Vaccines in Non/Low-response Populations
Condition: Vaccination; Complications, Reaction, Serum
Intervention: Biological: hepatitis B vaccine
11 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
12 Completed Observational Study of Immune Response to Hepatitis B Childhood Booster
Condition: Healthy
Intervention: Biological: Engerix B®, a recombinant hepatitis B vaccine
13 Completed Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
Condition: Hepatitis B
Intervention: Biological: Engerix™-B Kinder
14 Unknown  Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Condition: Hepatitis B
Interventions: Drug: Entecavir;   Drug: Entecavir, Adefovir
15 Completed Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: PegIFN alfa-2b
16 Completed Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants
Conditions: Haemophilus Influenzae Type b;   Diphtheria;   Whole Cell Pertussis;   Hepatitis B;   Tetanus
Intervention: Biological: DTPw-HBV/Hib-MenAC conjugate vaccine
17 Completed Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth
Condition: Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis
Intervention: Biological: DTPw-HBV/Hib-MenAC conjugate vaccine
18 Recruiting Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy
Condition: Chronic Hepatitis B
19 Completed A Study of the Immune Response to Heplisav in Healthy Older Adults
Condition: Hepatitis B
Intervention: Biological: HEPLISAV
20 Unknown  HBsAg Related Response Guided Therapy
Condition: Hepatitis B, Chronic
Interventions: Drug: Peginterferon alfa-2a;   Drug: Entecavir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years